Comorbidity characteristics of multiple myeloma patients diagnosed in Finland 2005-2016
Our recent RWE study detailed the comorbidity burden of Finnish multiple myeloma (MM) patients diagnosed between 2005 and 2016.
Medaffcon’s first annual customer evening was held 6th of April in Espoo Museum of Modern Arts – EMMA. The evening will become an annual tradition.
Medaffcon received over 100 enrollments for the evening representing 52 different organizations in the fields of healthcare and pharmaceuticals.
We want to thank all who attended the evening!
Medaffcon experts will gather summaries from all the speeches which will be published here on our Latest News webpage during April and May. Furthermore, in the end of May all material relating to the event will be wrapped up into a newsletter and sent to all the participants. Sign up for our newsletter and ensure that you receive all the event material!
We thank all the participants, the catering representatives and EMMA staff for making this evening possible.
Remember to stay alert as our second annual customer evening comes along next spring!
Tuuli Tuompo
Marketing Manager
+358 40 158 78 30
tuuli.tuompo@medaffcon.fi
Our recent RWE study detailed the comorbidity burden of Finnish multiple myeloma (MM) patients diagnosed between 2005 and 2016.
How to review and analyse a million sentences? Text mining decreased the work of clinical experts and accelerated the research process.
Heini Honkanen has been appointed as Medaffcon’s Market Access Lead. The new Market Access Team was created when the previous Price and Reimbursement and HE & Access Teams were merged.